Concepedia
Statistics
Publications
7
Citations
306
H-Index
Active since
2012
Affiliations
GlaxoSmithKline (United States)(Current)
Research Triangle Park Foundation
GlaxoSmithKline (United Kingdom)
PAREXEL International (United States)
Age UK
Laura R. Parham is an author at GlaxoSmithKline (United States) specializing in pharmacology, medicine, and immunogenetics.
Publications per year
2012–2020
Prospective Validation of <i>HLA-DRB1</i>*<i>07:01</i> Allele Carriage As a Predictive Risk Factor for Lapatinib-Induced Liver Injury
Daniel J. Schaid, Colin F. Spraggs, Shannon K. McDonnell et al. · Journal of Clinical Oncology · 2014 · 76 citations
Medicine, Oncology, Pharmacology +17
Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01
Laura R. Parham, Linda P. Briley, L Li et al. · The Pharmacogenomics Journal · 2015 · 63 citations · Full text
Life Sciences, Genetics, Immunology +17
A Randomized Phase 2 Study of an Anti–Amyloid β Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Philip J. Rosenfeld, Brian B. Berger, Elias Reichel et al. · Ophthalmology Retina · 2018 · 56 citations
Medicine, Neurology, Ophthalmology +10
Lapatinib-Induced Liver Injury Characterized by Class II HLA and Gilbert's Syndrome Genotypes
Colin F. Spraggs, Laura R. Parham, Christine M. Hunt et al. · Clinical Pharmacology & Therapeutics · 2012 · 50 citations
Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis
Lynn D. Condreay, Laura R. Parham, Xiaoyan A. Qu et al. · Rheumatology International · 2020 · 28 citations · Full text
Life Sciences, Immunology, Pharmacology +17
1–5 of 7